sirna News
Most Popular sirna Story
A billion-dollar lesson in RNAi economics
Roche's billion-dollar deal for gene-silencing technology (below) underscores once again what a hot commodity RNAi tech has become. And prices are rocketing up fast. Read more...
Latest Headlines
- June 25, 2008
- July 19, 2007
- July 12, 2007
- July 9, 2007
- July 6, 2007
- January 8, 2007
- November 15, 2006
- November 7, 2006
- November 2, 2006
- November 1, 2006
- August 15, 2006
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
